Rmr Wealth Builders Pfizer Inc Transaction History

Rmr Wealth Builders

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $14,344 - $16,766	-447 Reduced 4.32%	9,897 $328,000
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $6,357 - $7,355	176 Added 1.73%	10,344 $379,000
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $1,693 - $2,205	43 Added 0.42%	10,168 $414,000
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $22,753 - $29,702	-545 Reduced 5.11%	10,125 $519,000
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $68,090 - $83,121	1,556 Added 17.07%	10,670 $467,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $4,234 - $5,020	91 Added 1.01%	9,114 $478,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $36,462 - $45,181	797 Added 9.69%	9,023 $467,000
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $118,051 - $174,991	-2,857 Reduced 25.78%	8,226 $486,000
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $76,459 - $98,218	1,948 Added 21.32%	11,083 $477,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $157,070 - $177,934	-4,374 Reduced 32.38%	9,135 $358,000
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $230,880 - $260,386	6,894 Added 104.22%	13,509 $489,000
Q4 2020 Feb 26, 2021	BUY	$33.47 - $42.56 $171,199 - $217,694	5,115 Added 341.0%	6,615 $243,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $619,763 - $788,083	-18,517 Reduced 92.51%	1,500 $243,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $547,878 - $642,786	17,256 Added 624.99%	20,017 $735,000
Q2 2020 Aug 19, 2020	BUY	$30.12 - $36.54 $16,897 - $20,498	561 Added 25.5%	2,761 $91,000
Q4 2019 Mar 03, 2020	BUY	$32.92 - $37.36 $72,424 - $82,192	2,200 New	2,200 $86,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.